Polio Place

Opportunity to Participate in Research

For more than 10 years, researchers have explored using IVIg to help improve quality of life of polio survivors. The article linked below lists the medical articles published on this topic. To find the abstracts, go to PHI’s Polio Place. 

Also in the article below is a link to the worldwide centers and the person to contact to find out more about participation. Not all of the centers are recruiting yet. The centers in the US are University of California Los Angeles, Washington University in St. Louis, SUNY Upstate Medical University (Syracuse) and Thomas Jefferson University Hospital (Philadelphia). Canadian centers include Toronto General Hospital and Montreal Neurological Institute, McGill University.

A Multicenter, Multi-country Study of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF is underway. Also, see https://clinicaltrials.gov/ct2/show/study/NCT02176863#contacts.